<SEC-DOCUMENT>0000899243-19-012560-index.html : 20190507 <SEC-HEADER>0000899243-19-012560.hdr.sgml : 20190507 <ACCEPTANCE-DATETIME>20190507190056 ACCESSION NUMBER: 0000899243-19-012560 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190507 DATE AS OF CHANGE: 20190507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aperture Venture Partners IV, L.P. CENTRAL INDEX KEY: 0001659119 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 19804675 BUSINESS ADDRESS: STREET 1: 645 MADISON AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 758-7325 MAIL ADDRESS: STREET 1: 645 MADISON AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aperture Ventures IV Management, LLC CENTRAL INDEX KEY: 0001775271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 19804676 BUSINESS ADDRESS: STREET 1: 645 MADISON AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-758-7325 MAIL ADDRESS: STREET 1: 645 MADISON AVENUE, 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>doc3.xml <DESCRIPTION>FORM 3 SUBMISSION <TEXT> Document 1 - file: doc3.html
Document 1 - RAW XML: doc3.xml
</DOCUMENT> </SEC-DOCUMENT>